Shenzhen Chipscreen Biosciences Co Net Asset Quality Index
Shenzhen Chipscreen Biosciences Co net asset quality index. Shenzhen Chipscreen Biosciences Co (688321) has a Net Asset Quality Index of 45.6% as of September 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of CN¥3.63 Billion minus total liabilities of CN¥1.98 Billion yields net assets of CN¥1.66 Billion. A higher index indicates a stronger, lower-leverage balance sheet. Check Shenzhen Chipscreen Biosciences Co cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
Quality Index
Net Assets
Total Assets
Total Liabilities
Net Asset Quality Index of Shenzhen Chipscreen Biosciences Co (2016–2024)
Net asset quality index of Shenzhen Chipscreen Biosciences Co from 2016 to 2024. This chart shows how Shenzhen Chipscreen Biosciences Co's Net Asset Quality Index has evolved across 9 annual periods from 2016 to 2024. As of September 2025, the index stands at 45.6%, representing net assets of CN¥1.66 Billion against total assets of CN¥3.63 Billion CNY. See 688321 net assets for net asset value and shareholders' equity analysis.
Shenzhen Chipscreen Biosciences Co Net Asset Quality Index by Year (2016–2024)
Shenzhen Chipscreen Biosciences Co net asset quality index by year from 2016 to 2024. The table below presents the year-by-year Net Asset Quality Index for Shenzhen Chipscreen Biosciences Co from 2016 to 2024, covering 9 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see Shenzhen Chipscreen Biosciences Co (688321) total market value.
| Year | Quality Index | Net Assets (CNY) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 48.6% | CN¥1.58 Billion | CN¥3.25 Billion | CN¥1.67 Billion | ▼ -4.7 pp |
| 2023 | 53.4% | CN¥1.71 Billion | CN¥3.20 Billion | CN¥1.49 Billion | ▼ -1.0 pp |
| 2022 | 54.4% | CN¥1.58 Billion | CN¥2.90 Billion | CN¥1.32 Billion | ▼ -20.4 pp |
| 2021 | 74.8% | CN¥1.42 Billion | CN¥1.89 Billion | CN¥476.79 Million | ▼ -11.7 pp |
| 2020 | 86.5% | CN¥1.49 Billion | CN¥1.73 Billion | CN¥232.44 Million | ▲ +1.0 pp |
| 2019 | 85.5% | CN¥1.45 Billion | CN¥1.69 Billion | CN¥245.10 Million | ▲ +18.9 pp |
| 2018 | 66.6% | CN¥476.90 Million | CN¥716.34 Million | CN¥239.44 Million | ▼ -2.1 pp |
| 2017 | 68.7% | CN¥450.55 Million | CN¥656.02 Million | CN¥205.47 Million | ▲ +15.7 pp |
| 2016 | 52.9% | CN¥213.40 Million | CN¥403.13 Million | CN¥189.73 Million | — |